Back to Search Start Over

Exploring the chemical space around chrysin to develop novel vascular Ca V 1.2 channel blockers, promising vasorelaxant agents.

Authors :
Falbo F
Carullo G
Panti A
Spiga O
Gianibbi B
Ahmed A
Campiani G
Ramunno A
Aiello F
Fusi F
Source :
Archiv der Pharmazie [Arch Pharm (Weinheim)] 2024 Nov; Vol. 357 (11), pp. e2400536. Date of Electronic Publication: 2024 Sep 06.
Publication Year :
2024

Abstract

The flavonoid chrysin is an effective vascular Ca <subscript>V</subscript> 1.2 channel blocker. The aim of this study was to explore the chemical space around chrysin to identify the structural features that can be modified to develop novel and more effective blockers. Four derivatives (Chrysin 1-4) were synthesised and a functional, electrophysiology and molecular docking approach was pursued to assess their binding mode to Ca <subscript>V</subscript> 1.2 channels and their activity in vascular preparations. Methylation of the 5- and 7-OH of the chrysin backbone caused a marked reduction of the Ca <superscript>2+</superscript> antagonistic potency and efficacy. However, C-8 derivatives showed biophysical features similar to those of the parent compound and, like nicardipine, bound with high affinity to and stabilised the Ca <subscript>V</subscript> 1.2 channel in its inactivated state. The vasorelaxant effects of the four derivatives appeared vessel-specific, addressing the molecules' derivatization towards different targets. In conclusion, the scaffold of chrysin may be considered a valuable starting point for the development of innovative vascular Ca <subscript>V</subscript> 1.2 channel blockers.<br /> (© 2024 Deutsche Pharmazeutische Gesellschaft.)

Details

Language :
English
ISSN :
1521-4184
Volume :
357
Issue :
11
Database :
MEDLINE
Journal :
Archiv der Pharmazie
Publication Type :
Academic Journal
Accession number :
39239992
Full Text :
https://doi.org/10.1002/ardp.202400536